VERU Veru Inc.

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.

$12.64  -0.01 (-0.04%)
As of 05/27/2022 14:46:14 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Consumer Staples
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  80,073,683
Average volume:  21,101,785
Market cap:   $990,511,459
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDFBQ66
Valuation   (See tab for details)
PE ratio:   -36.74
PB ratio:   7.44
PS ratio:   16.38
Return on equity:   -20.25%
Net income %:   -45.56%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy